124 related articles for article (PubMed ID: 34815134)
21. Endogenous contrast T1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients.
Wang C; Zheng J; Sun J; Wang Y; Xia R; Yin Q; Chen W; Xu Z; Liao J; Zhang B; Gao F
J Cardiol; 2015 Dec; 66(6):520-6. PubMed ID: 25981868
[TBL] [Abstract][Full Text] [Related]
22. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
[TBL] [Abstract][Full Text] [Related]
23. Segmental longitudinal strain as the most accurate predictor of the patchy pattern late gadolinium enhancement in hypertrophic cardiomyopathy.
Wabich E; Dorniak K; Zienciuk-Krajka A; Nowak R; Raczak G; Daniłowicz-Szymanowicz L
J Cardiol; 2021 May; 77(5):475-481. PubMed ID: 33246844
[TBL] [Abstract][Full Text] [Related]
24. Toward Replacing Late Gadolinium Enhancement With Artificial Intelligence Virtual Native Enhancement for Gadolinium-Free Cardiovascular Magnetic Resonance Tissue Characterization in Hypertrophic Cardiomyopathy.
Zhang Q; Burrage MK; Lukaschuk E; Shanmuganathan M; Popescu IA; Nikolaidou C; Mills R; Werys K; Hann E; Barutcu A; Polat SD; ; Salerno M; Jerosch-Herold M; Kwong RY; Watkins HC; Kramer CM; Neubauer S; Ferreira VM; Piechnik SK
Circulation; 2021 Aug; 144(8):589-599. PubMed ID: 34229451
[TBL] [Abstract][Full Text] [Related]
25. Correlation of electrocardiographic changes and myocardial fibrosis in patients with hypertrophic cardiomyopathy detected by cardiac magnetic resonance imaging.
Song BG; Yang HS; Hwang HK; Kang GH; Park YH; Chun WJ; Oh JH
Clin Cardiol; 2013 Jan; 36(1):31-5. PubMed ID: 23070984
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy.
Green JJ; Berger JS; Kramer CM; Salerno M
JACC Cardiovasc Imaging; 2012 Apr; 5(4):370-7. PubMed ID: 22498326
[TBL] [Abstract][Full Text] [Related]
27. The Clinical Prognosis of Presence and Location of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Imaging in Patients with Hypertrophic Cardiomyopathy: a Single-Center Cohort Study.
Li X; Lai L; Luo R; Yang H; Ma H; Yang Z; Zhao S; Su W; Hua W
J Cardiovasc Transl Res; 2021 Oct; 14(5):1001-1016. PubMed ID: 33629154
[TBL] [Abstract][Full Text] [Related]
28. Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications.
Raman B; Ariga R; Spartera M; Sivalokanathan S; Chan K; Dass S; Petersen SE; Daniels MJ; Francis J; Smillie R; Lewandowski AJ; Ohuma EO; Rodgers C; Kramer CM; Mahmod M; Watkins H; Neubauer S
Eur Heart J Cardiovasc Imaging; 2019 Feb; 20(2):157-167. PubMed ID: 30358845
[TBL] [Abstract][Full Text] [Related]
29. Native T1-mapping for non-contrast assessment of myocardial fibrosis in patients with hypertrophic cardiomyopathy--comparison with late enhancement quantification.
Małek ŁA; Werys K; Kłopotowski M; Śpiewak M; Miłosz-Wieczorek B; Mazurkiewicz Ł; Petryka-Mazurkiewicz J; Marczak M; Witkowski A
Magn Reson Imaging; 2015 Jul; 33(6):718-24. PubMed ID: 25863138
[TBL] [Abstract][Full Text] [Related]
30. [Late gadolinium enhancement distribution pattern of left ventricular wall in patients with dilated cardiomyopathy: a preliminary study].
Li R; Cui C; Lan T; Chen XY; Yin G; Lu MJ; Zhao SH
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Nov; 48(11):922-929. PubMed ID: 33210863
[No Abstract] [Full Text] [Related]
31. Late Gadolinium Enhancement for Prediction of Mutation-Positive Hypertrophic Cardiomyopathy on the Basis of Panel-Wide Sequencing.
Teramoto R; Fujino N; Konno T; Nomura A; Nagata Y; Tsuda T; Tada H; Sakata K; Yamagishi M; Hayashi K; Kawashiri MA
Circ J; 2018 Mar; 82(4):1139-1148. PubMed ID: 29398688
[TBL] [Abstract][Full Text] [Related]
32. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
[TBL] [Abstract][Full Text] [Related]
33. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
[TBL] [Abstract][Full Text] [Related]
34. Distribution of Hypertrophy and Late Gadolinium Enhancement in Children and Adolescents with Hypertrophic Cardiomyopathy.
Windram JD; Benson LN; Dragelescu A; Yoo SJ; Mertens L; Wong D; Grosse-Wortmann L
Congenit Heart Dis; 2015; 10(6):E258-67. PubMed ID: 26193909
[TBL] [Abstract][Full Text] [Related]
35. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.
Aquaro GD; Positano V; Pingitore A; Strata E; Di Bella G; Formisano F; Spirito P; Lombardi M
J Cardiovasc Magn Reson; 2010 Apr; 12(1):21. PubMed ID: 20374627
[TBL] [Abstract][Full Text] [Related]
36. The relationship between electrocardiographic changes and CMR features in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.
Chen X; Zhao T; Lu M; Yin G; Xiangli W; Jiang S; Prasad S; Zhao S
Int J Cardiovasc Imaging; 2014 Jun; 30 Suppl 1():55-63. PubMed ID: 24723003
[TBL] [Abstract][Full Text] [Related]
37. Quantification and significance of diffuse myocardial fibrosis and diastolic dysfunction in childhood hypertrophic cardiomyopathy.
Hussain T; Dragulescu A; Benson L; Yoo SJ; Meng H; Windram J; Wong D; Greiser A; Friedberg M; Mertens L; Seed M; Redington A; Grosse-Wortmann L
Pediatr Cardiol; 2015 Jun; 36(5):970-8. PubMed ID: 25605038
[TBL] [Abstract][Full Text] [Related]
38. Machine learning phenotyping of scarred myocardium from cine in hypertrophic cardiomyopathy.
Mancio J; Pashakhanloo F; El-Rewaidy H; Jang J; Joshi G; Csecs I; Ngo L; Rowin E; Manning W; Maron M; Nezafat R
Eur Heart J Cardiovasc Imaging; 2022 Mar; 23(4):532-542. PubMed ID: 33779725
[TBL] [Abstract][Full Text] [Related]
39. T-wave inversions related to left ventricular basal hypertrophy and myocardial fibrosis in non-apical hypertrophic cardiomyopathy: a cardiovascular magnetic resonance imaging study.
Chen X; Zhao S; Zhao T; Lu M; Yin G; Jiang S; Prasad S
Eur J Radiol; 2014 Feb; 83(2):297-302. PubMed ID: 24332848
[TBL] [Abstract][Full Text] [Related]
40. Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.
Dass S; Suttie JJ; Piechnik SK; Ferreira VM; Holloway CJ; Banerjee R; Mahmod M; Cochlin L; Karamitsos TD; Robson MD; Watkins H; Neubauer S
Circ Cardiovasc Imaging; 2012 Nov; 5(6):726-33. PubMed ID: 23071146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
